Go Pro
→ Here’s the stock symbol I’ve promised (From Stansberry Research) (Ad)tc pixel Free HNGE Stock Alerts

Hinge Health (HNGE) Competitors

Hinge Health logo
$93.44 +1.05 (+1.14%)
Closing price 03:59 PM Eastern
Extended Trading
$92.83 -0.61 (-0.65%)
As of 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

HNGE vs. LH, DGX, GH, FMS, and BTSG

Should you buy Hinge Health stock or one of its competitors? Hinge Health's main competitors and comparable companies include Labcorp (LH), Quest Diagnostics (DGX), Guardant Health (GH), Fresenius Medical Care AG & Co. KGaA (FMS), and BrightSpring Health Services (BTSG). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Hinge Health compare to Labcorp?

Hinge Health (NYSE:HNGE) and Labcorp (NYSE:LH) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, valuation, analyst recommendations, media sentiment, earnings, risk and institutional ownership.

95.9% of Labcorp shares are held by institutional investors. 18.9% of Hinge Health shares are held by company insiders. Comparatively, 0.8% of Labcorp shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Hinge Health has a beta of 1.38, indicating that its share price is 38% more volatile than the broader market. Comparatively, Labcorp has a beta of 0.88, indicating that its share price is 12% less volatile than the broader market.

Hinge Health presently has a consensus target price of $101.93, suggesting a potential upside of 9.09%. Labcorp has a consensus target price of $336.36, suggesting a potential upside of 3.64%. Given Hinge Health's stronger consensus rating and higher probable upside, equities analysts clearly believe Hinge Health is more favorable than Labcorp.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hinge Health
1 Sell rating(s)
2 Hold rating(s)
14 Buy rating(s)
1 Strong Buy rating(s)
2.83
Labcorp
0 Sell rating(s)
3 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.75

In the previous week, Hinge Health had 3 more articles in the media than Labcorp. MarketBeat recorded 18 mentions for Hinge Health and 15 mentions for Labcorp. Labcorp's average media sentiment score of 0.66 beat Hinge Health's score of 0.26 indicating that Labcorp is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hinge Health
7 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Labcorp
6 Very Positive mention(s)
2 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Hinge Health has a net margin of 15.15% compared to Labcorp's net margin of 6.99%. Hinge Health's return on equity of 51.60% beat Labcorp's return on equity.

Company Net Margins Return on Equity Return on Assets
Hinge Health15.15% 51.60% 14.16%
Labcorp 6.99%16.74%7.81%

Labcorp has higher revenue and earnings than Hinge Health. Labcorp is trading at a lower price-to-earnings ratio than Hinge Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hinge Health$587.86M12.83-$528.26M$1.2873.00
Labcorp$13.95B1.89$876.50M$12.0926.84

Summary

Hinge Health beats Labcorp on 12 of the 17 factors compared between the two stocks.

How does Hinge Health compare to Quest Diagnostics?

Quest Diagnostics (NYSE:DGX) and Hinge Health (NYSE:HNGE) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, earnings, risk, dividends, institutional ownership, media sentiment and profitability.

Quest Diagnostics has a beta of 0.55, indicating that its stock price is 45% less volatile than the broader market. Comparatively, Hinge Health has a beta of 1.38, indicating that its stock price is 38% more volatile than the broader market.

88.1% of Quest Diagnostics shares are held by institutional investors. 0.9% of Quest Diagnostics shares are held by insiders. Comparatively, 18.9% of Hinge Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Quest Diagnostics has higher revenue and earnings than Hinge Health. Quest Diagnostics is trading at a lower price-to-earnings ratio than Hinge Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Quest Diagnostics$11.04B2.47$992M$9.4226.26
Hinge Health$587.86M12.83-$528.26M$1.2873.00

In the previous week, Quest Diagnostics had 3 more articles in the media than Hinge Health. MarketBeat recorded 21 mentions for Quest Diagnostics and 18 mentions for Hinge Health. Quest Diagnostics' average media sentiment score of 0.74 beat Hinge Health's score of 0.26 indicating that Quest Diagnostics is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Quest Diagnostics
9 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Hinge Health
7 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Quest Diagnostics currently has a consensus target price of $236.31, suggesting a potential downside of 4.49%. Hinge Health has a consensus target price of $101.93, suggesting a potential upside of 9.09%. Given Hinge Health's stronger consensus rating and higher possible upside, analysts plainly believe Hinge Health is more favorable than Quest Diagnostics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Quest Diagnostics
0 Sell rating(s)
7 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.54
Hinge Health
1 Sell rating(s)
2 Hold rating(s)
14 Buy rating(s)
1 Strong Buy rating(s)
2.83

Hinge Health has a net margin of 15.15% compared to Quest Diagnostics' net margin of 9.18%. Hinge Health's return on equity of 51.60% beat Quest Diagnostics' return on equity.

Company Net Margins Return on Equity Return on Assets
Quest Diagnostics9.18% 16.01% 7.27%
Hinge Health 15.15%51.60%14.16%

Summary

Hinge Health beats Quest Diagnostics on 10 of the 16 factors compared between the two stocks.

How does Hinge Health compare to Guardant Health?

Hinge Health (NYSE:HNGE) and Guardant Health (NASDAQ:GH) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, media sentiment, analyst recommendations, dividends, profitability, risk, institutional ownership and earnings.

Hinge Health presently has a consensus target price of $101.93, suggesting a potential upside of 9.09%. Guardant Health has a consensus target price of $188.13, suggesting a potential upside of 7.56%. Given Hinge Health's higher probable upside, equities analysts plainly believe Hinge Health is more favorable than Guardant Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hinge Health
1 Sell rating(s)
2 Hold rating(s)
14 Buy rating(s)
1 Strong Buy rating(s)
2.83
Guardant Health
1 Sell rating(s)
0 Hold rating(s)
24 Buy rating(s)
1 Strong Buy rating(s)
2.96

Hinge Health has a beta of 1.38, indicating that its stock price is 38% more volatile than the broader market. Comparatively, Guardant Health has a beta of 1.57, indicating that its stock price is 57% more volatile than the broader market.

92.6% of Guardant Health shares are owned by institutional investors. 18.9% of Hinge Health shares are owned by company insiders. Comparatively, 5.6% of Guardant Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Guardant Health had 1 more articles in the media than Hinge Health. MarketBeat recorded 19 mentions for Guardant Health and 18 mentions for Hinge Health. Guardant Health's average media sentiment score of 0.68 beat Hinge Health's score of 0.26 indicating that Guardant Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hinge Health
7 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Guardant Health
8 Very Positive mention(s)
1 Positive mention(s)
7 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Positive

Guardant Health has higher revenue and earnings than Hinge Health. Guardant Health is trading at a lower price-to-earnings ratio than Hinge Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hinge Health$587.86M12.83-$528.26M$1.2873.00
Guardant Health$982.02M23.90-$416.28M-$3.49N/A

Hinge Health has a net margin of 15.15% compared to Guardant Health's net margin of -38.33%. Hinge Health's return on equity of 51.60% beat Guardant Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Hinge Health15.15% 51.60% 14.16%
Guardant Health -38.33%N/A -25.40%

Summary

Guardant Health beats Hinge Health on 9 of the 16 factors compared between the two stocks.

How does Hinge Health compare to Fresenius Medical Care AG & Co. KGaA?

Hinge Health (NYSE:HNGE) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, risk, valuation, analyst recommendations, dividends, earnings and profitability.

Hinge Health has a beta of 1.38, indicating that its share price is 38% more volatile than the broader market. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 0.76, indicating that its share price is 24% less volatile than the broader market.

Hinge Health currently has a consensus price target of $101.93, indicating a potential upside of 9.09%. Fresenius Medical Care AG & Co. KGaA has a consensus price target of $23.57, indicating a potential upside of 2.71%. Given Hinge Health's stronger consensus rating and higher probable upside, equities research analysts clearly believe Hinge Health is more favorable than Fresenius Medical Care AG & Co. KGaA.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hinge Health
1 Sell rating(s)
2 Hold rating(s)
14 Buy rating(s)
1 Strong Buy rating(s)
2.83
Fresenius Medical Care AG & Co. KGaA
5 Sell rating(s)
6 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.55

In the previous week, Hinge Health had 18 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 18 mentions for Hinge Health and 0 mentions for Fresenius Medical Care AG & Co. KGaA. Hinge Health's average media sentiment score of 0.26 beat Fresenius Medical Care AG & Co. KGaA's score of 0.00 indicating that Hinge Health is being referred to more favorably in the media.

Company Overall Sentiment
Hinge Health Neutral
Fresenius Medical Care AG & Co. KGaA Neutral

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Hinge Health. Fresenius Medical Care AG & Co. KGaA is trading at a lower price-to-earnings ratio than Hinge Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hinge Health$587.86M12.83-$528.26M$1.2873.00
Fresenius Medical Care AG & Co. KGaA$22.20B0.56$1.11B$1.9311.89

8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. 18.9% of Hinge Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Hinge Health has a net margin of 15.15% compared to Fresenius Medical Care AG & Co. KGaA's net margin of 4.83%. Hinge Health's return on equity of 51.60% beat Fresenius Medical Care AG & Co. KGaA's return on equity.

Company Net Margins Return on Equity Return on Assets
Hinge Health15.15% 51.60% 14.16%
Fresenius Medical Care AG & Co. KGaA 4.83%9.28%4.16%

Summary

Hinge Health beats Fresenius Medical Care AG & Co. KGaA on 13 of the 17 factors compared between the two stocks.

How does Hinge Health compare to BrightSpring Health Services?

BrightSpring Health Services (NASDAQ:BTSG) and Hinge Health (NYSE:HNGE) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, institutional ownership, analyst recommendations, profitability, risk and earnings.

BrightSpring Health Services currently has a consensus target price of $70.71, indicating a potential upside of 19.92%. Hinge Health has a consensus target price of $101.93, indicating a potential upside of 9.09%. Given BrightSpring Health Services' stronger consensus rating and higher probable upside, equities analysts plainly believe BrightSpring Health Services is more favorable than Hinge Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BrightSpring Health Services
0 Sell rating(s)
0 Hold rating(s)
18 Buy rating(s)
2 Strong Buy rating(s)
3.10
Hinge Health
1 Sell rating(s)
2 Hold rating(s)
14 Buy rating(s)
1 Strong Buy rating(s)
2.83

BrightSpring Health Services has a beta of 1.84, suggesting that its stock price is 84% more volatile than the broader market. Comparatively, Hinge Health has a beta of 1.38, suggesting that its stock price is 38% more volatile than the broader market.

In the previous week, Hinge Health had 11 more articles in the media than BrightSpring Health Services. MarketBeat recorded 18 mentions for Hinge Health and 7 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 1.13 beat Hinge Health's score of 0.26 indicating that BrightSpring Health Services is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BrightSpring Health Services
5 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Hinge Health
7 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Hinge Health has a net margin of 15.15% compared to BrightSpring Health Services' net margin of 2.55%. Hinge Health's return on equity of 51.60% beat BrightSpring Health Services' return on equity.

Company Net Margins Return on Equity Return on Assets
BrightSpring Health Services2.55% 16.73% 5.24%
Hinge Health 15.15%51.60%14.16%

BrightSpring Health Services has higher revenue and earnings than Hinge Health. BrightSpring Health Services is trading at a lower price-to-earnings ratio than Hinge Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BrightSpring Health Services$12.91B0.90$190.67M$1.6635.52
Hinge Health$587.86M12.83-$528.26M$1.2873.00

Summary

BrightSpring Health Services beats Hinge Health on 9 of the 15 factors compared between the two stocks.

Get Hinge Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for HNGE and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HNGE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HNGE vs. The Competition

Export
MetricHinge HealthHealthcare Providers & Services IndustryHealthcare SectorNYSE Exchange
Market Cap$7.46B$9.90B$7.22B$23.16B
Dividend YieldN/A2.60%2.57%3.59%
P/E Ratio73.0034.18273.5228.22
Price / Sales12.834.98647.0520.04
Price / CashN/A125.5976.4033.71
Price / Book41.345.3310.354.66
Net Income-$528.26M$313.45M$3.49B$1.07B
7 Day Performance2.01%3.22%-1.78%-2.12%
1 Month Performance5.97%-0.42%-1.48%-4.92%
1 Year Performance58.86%17.09%18.20%8.27%

Hinge Health Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HNGE
Hinge Health
3.3736 of 5 stars		$93.44
+1.1%		$101.93
+9.1%		+59.7%$7.46B$587.86M73.001,437
LH
Labcorp
3.8726 of 5 stars		$326.83
0.0%		$330.00
+1.0%		+17.5%$26.51B$13.95B27.0371,000
DGX
Quest Diagnostics
3.9261 of 5 stars		$236.75
-0.2%		$235.31
-0.6%		+36.8%$26.13B$11.04B25.1357,000
GH
Guardant Health
2.2371 of 5 stars		$161.41
flat		$183.78
+13.9%		+220.6%$21.66B$982.02MN/A2,506
FMS
Fresenius Medical Care AG & Co. KGaA
1.854 of 5 stars		$22.66
flat		$23.57
+4.0%		-7.0%$12.17B$22.20B11.741,488

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NYSE:HNGE) was last updated on 9/16/2026 by MarketBeat.com Staff.
From Our Partners
Your backdoor link (still works)
Bill Poulos is offering a private link to download his book Simple Options Trading For Beginners, bypassing th...
Profits Run | Sponsoredtc pixel
I don't write about politics. Until today.
Polls have favored a House flip all summer, and forecasters now expect Washington to change hands in November....
American Alternative | Sponsoredtc pixel
A “bloodbath” Is Coming
Reports suggest some Silicon Valley billionaires are stockpiling gold, guns, and gas masks - or leaving the co...
TradeSmith | Sponsoredtc pixel
The national debt just passed $39 trillion
The U.S. national debt just topped $39 trillion, up nearly $3 trillion in a single year and on pace to hit $40...
US Gold Bureau | Sponsoredtc pixel
Why major institutions are piling into this digital asset now
BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...
Awesomely | Sponsoredtc pixel
A new kind of civil war is coming after election day?
Across America, AI-driven backlash is fueling protests, lawsuits, and moratoria that could reshape the politic...
Stansberry Research | Sponsoredtc pixel
Trump goes "all-in" on Grand Canyon energy breakthrough
A drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...
Behind the Markets | Sponsoredtc pixel
MILLIONAIRE MASTERCLASS INVITE: Altucher
James Altucher says Elon Musk is preparing an unprecedented project set to surface on September 25. Altuche...
Paradigm Press | Sponsoredtc pixel